Latest news with #RSInvestments
Yahoo
23-05-2025
- Business
- Yahoo
Factors Behind Zebra Technologies' (ZBRA) Weakness
RS Investments, an investment management company, released its 'RS Large Cap Value Strategy' first quarter 2025 investor letter. A copy of the letter can be downloaded here. In the first quarter, the strategy underperformed its benchmark, the Russell 1000 Value Index (the 'Index'), and returned 1.57% (net) versus a return of 2.14% for the Index. The strong performance from stock selection in Consumer Discretionary and Utilities aided relative performance in the quarter, while stock selection in Materials and Information Technology detracted. In addition, you can check the fund's top 5 holdings to determine its best picks for 2025. In its first-quarter 2025 investor letter, RS Large Cap Value Strategy highlighted stocks such as Zebra Technologies Corporation (NASDAQ:ZBRA). Zebra Technologies Corporation (NASDAQ:ZBRA) offers enterprise asset intelligence solutions in the automatic identification and data capture solutions industry. The one-month return of Zebra Technologies Corporation (NASDAQ:ZBRA) was 18.14%, and its shares lost 11.02% of their value over the last 52 weeks. On May 22, 2025, Zebra Technologies Corporation (NASDAQ:ZBRA) stock closed at $288.36 per share with a market capitalization of $14.664 billion. RS Large Cap Value Strategy stated the following regarding Zebra Technologies Corporation (NASDAQ:ZBRA) in its Q1 2025 investor letter: "Zebra Technologies Corporation (NASDAQ:ZBRA), a provider of physical asset tracking software and hardware, declined 26% during the quarter. Our long term thesis is that manufacturing, retail, distribution, and healthcare companies will invest in automation and tracking technologies to improve efficiency, margins, and customer satisfaction. Long before we purchased the stock, it slumped in 2022 after excessive purchases from online retailers and distribution centers during Covid. We eventually initiated a position in August 2023 after we identified that the Covid purchases had been worked through. The stock then performed well in 2024 as our thesis played out. However, in early 2025, management provided conservative guidance due to concerns about tariffs and consumer spending. While these political and macro concerns will produce some headwinds, our long-term thesis remains intact, so we continue to hold our position." A tech-savvy employee testing a real-time location system in a warehouse. Zebra Technologies Corporation (NASDAQ:ZBRA) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 45 hedge fund portfolios held Zebra Technologies Corporation (NASDAQ:ZBRA) at the end of the fourth quarter compared to 42 in the third quarter. Zebra Technologies Corporation's (NASDAQ:ZBRA) Q1 2025 revenue grew 12% year-over-year to $1.31 billion. While we acknowledge the potential of Zebra Technologies Corporation (NASDAQ:ZBRA) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as NVIDIA but that trades at less than 5 times its earnings, check out our report about the undervalued AI stock set for massive gains. In another article, we covered Zebra Technologies Corporation (NASDAQ:ZBRA) and shared the list of worst performing stocks in the S&P 500 so far in 2025. In addition, please check out our hedge fund investor letters Q1 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: Michael Burry Is Selling These Stocks and A New Dawn Is Coming to US Stocks. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
23-05-2025
- Business
- Yahoo
Factors Behind Zebra Technologies' (ZBRA) Weakness
RS Investments, an investment management company, released its 'RS Large Cap Value Strategy' first quarter 2025 investor letter. A copy of the letter can be downloaded here. In the first quarter, the strategy underperformed its benchmark, the Russell 1000 Value Index (the 'Index'), and returned 1.57% (net) versus a return of 2.14% for the Index. The strong performance from stock selection in Consumer Discretionary and Utilities aided relative performance in the quarter, while stock selection in Materials and Information Technology detracted. In addition, you can check the fund's top 5 holdings to determine its best picks for 2025. In its first-quarter 2025 investor letter, RS Large Cap Value Strategy highlighted stocks such as Zebra Technologies Corporation (NASDAQ:ZBRA). Zebra Technologies Corporation (NASDAQ:ZBRA) offers enterprise asset intelligence solutions in the automatic identification and data capture solutions industry. The one-month return of Zebra Technologies Corporation (NASDAQ:ZBRA) was 18.14%, and its shares lost 11.02% of their value over the last 52 weeks. On May 22, 2025, Zebra Technologies Corporation (NASDAQ:ZBRA) stock closed at $288.36 per share with a market capitalization of $14.664 billion. RS Large Cap Value Strategy stated the following regarding Zebra Technologies Corporation (NASDAQ:ZBRA) in its Q1 2025 investor letter: "Zebra Technologies Corporation (NASDAQ:ZBRA), a provider of physical asset tracking software and hardware, declined 26% during the quarter. Our long term thesis is that manufacturing, retail, distribution, and healthcare companies will invest in automation and tracking technologies to improve efficiency, margins, and customer satisfaction. Long before we purchased the stock, it slumped in 2022 after excessive purchases from online retailers and distribution centers during Covid. We eventually initiated a position in August 2023 after we identified that the Covid purchases had been worked through. The stock then performed well in 2024 as our thesis played out. However, in early 2025, management provided conservative guidance due to concerns about tariffs and consumer spending. While these political and macro concerns will produce some headwinds, our long-term thesis remains intact, so we continue to hold our position." A tech-savvy employee testing a real-time location system in a warehouse. Zebra Technologies Corporation (NASDAQ:ZBRA) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 45 hedge fund portfolios held Zebra Technologies Corporation (NASDAQ:ZBRA) at the end of the fourth quarter compared to 42 in the third quarter. Zebra Technologies Corporation's (NASDAQ:ZBRA) Q1 2025 revenue grew 12% year-over-year to $1.31 billion. While we acknowledge the potential of Zebra Technologies Corporation (NASDAQ:ZBRA) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as NVIDIA but that trades at less than 5 times its earnings, check out our report about the undervalued AI stock set for massive gains. In another article, we covered Zebra Technologies Corporation (NASDAQ:ZBRA) and shared the list of worst performing stocks in the S&P 500 so far in 2025. In addition, please check out our hedge fund investor letters Q1 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: Michael Burry Is Selling These Stocks and A New Dawn Is Coming to US Stocks. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
23-05-2025
- Business
- Yahoo
Key Drivers Behind AbbVie's (ABBV) Performance
RS Investments, an investment management company, released its 'RS Large Cap Value Strategy' first quarter 2025 investor letter. A copy of the letter can be downloaded here. In the first quarter, the strategy underperformed its benchmark, the Russell 1000 Value Index (the 'Index'), and returned 1.57% (net) versus a return of 2.14% for the Index. The strong performance from stock selection in Consumer Discretionary and Utilities aided relative performance in the quarter, while stock selection in Materials and Information Technology detracted. In addition, you can check the fund's top 5 holdings to determine its best picks for 2025. In its first-quarter 2025 investor letter, RS Large Cap Value Strategy highlighted stocks such as AbbVie Inc. (NYSE:ABBV). AbbVie Inc. (NYSE:ABBV) is a research-based biopharmaceutical company. The one-month return of AbbVie Inc. (NYSE:ABBV) was 1.20%, and its shares gained 15.34% of their value over the last 52 weeks. On May 22, 2025, AbbVie Inc. (NYSE:ABBV) stock closed at $182.54 per share with a market capitalization of $322.439 billion. RS Large Cap Value Strategy stated the following regarding AbbVie Inc. (NYSE:ABBV) in its Q1 2025 investor letter: "AbbVie Inc. (NYSE:ABBV) was a strong positive contributor to performance during the first quarter of 2025. The stock benefited from a confluence of company-specific and macro drivers, including robust fourth-quarter results reported in February and renewed investor interest in the pharmaceutical sector broadly. AbbVie's fourth quarter earnings exceeded expectations on both revenue and EPS, driven by continued growth in its immunology and neuroscience franchises, alongside stabilizing trends in Humira sales post loss of patent exclusivity. Importantly, during the first quarter AbbVie announced a large licensing deal with Gubra (a Danish biotech company) which gives AbbVie co-development and co commercialization rights on their lead clinical-stage obesity drug. While still early in development, the asset provides optionality in one of the most attractive therapeutic areas in biopharma today and underscores management's willingness to reposition the company for long-term growth beyond its core inflammation franchise. On the macro front, pharmaceutical stocks in general rebounded after several years of relative underperformance as investors sought exposure to defensive, high-margin business models trading at modest valuations relative to the broader market. We remain constructive on AbbVie and believe the company is well-positioned to deliver high-single-digit earnings growth through the end of the decade, supported by durable franchises, a promising pipeline, and a healthy balance sheet." A pharmacist handing out a pharmaceutical drug to a patient in a drug store or chemist. AbbVie Inc. (NYSE:ABBV) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 85 hedge fund portfolios held AbbVie Inc. (NYSE:ABBV) at the end of the fourth quarter, compared to 68 in the third quarter. While we acknowledge the potential of AbbVie Inc. (NYSE:ABBV) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as NVIDIA but that trades at less than 5 times its earnings, check out our report about the undervalued AI stock set for massive gains. In another article, we covered AbbVie Inc. (NYSE:ABBV) and shared Renaissance Large Cap Growth Strategy's views on the company. In addition, please check out our hedge fund investor letters Q1 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: Michael Burry Is Selling These Stocks and A New Dawn Is Coming to US Stocks. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
31-03-2025
- Business
- Yahoo
Should You Invest in Graphic Packaging (GPK)?
RS Investments, an investment management company, released its 'RS Concentrated All Cap Value Strategy' fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. The S&P 500® Index saw a 25% gain for the year, following a 23% increase in 2023. Such back-to-back years of over 20% returns are rare, highlighting the overall positive trend despite some year-end weakness. In the fourth quarter, the strategy outperformed its benchmark Russell 3000® Value Index (the 'Index') and returned 1.07% net versus a return of -1.94% for the Index. The strong performance from stock selection in Health Care and Utilities aided relative performance in the quarter, while stock selection in Real Estate and Consumer Staples detracted. In addition, you can check the fund's top 5 holdings to determine its best picks for 2024. In its fourth quarter 2024 investor letter, RS Concentrated All Cap Value Strategy emphasized stocks such as Graphic Packaging Holding Company (NYSE:GPK). Graphic Packaging Holding Company (NYSE:GPK) designs and manufactures consumer packaging products. The one-month return of Graphic Packaging Holding Company (NYSE:GPK) was -0.11%, and its shares lost 8.89% of their value over the last 52 weeks. On March 28, 2025, Graphic Packaging Holding Company (NYSE:GPK) stock closed at $26.12 per share with a market capitalization of $7.842 billion. RS Concentrated All Cap Value Strategy stated the following regarding Graphic Packaging Holding Company (NYSE:GPK) in its Q4 2024 investor letter: "Graphic Packaging Holding Company (NYSE:GPK) is an integrated provider of paperboard packaging, delivering cartons and containers for food, beverage and consumer products. In the most recent quarter, GPK experienced sluggish volumes as its customers are still seeing stagnant demand from consumers given price increases over the past year. While volume growth will be tepid in the short term, the company is still gaining share from other container materials such as plastic as its customers transition to more sustainable, paper based solutions. Also, the company is currently building a new facility in Texas after recently completing an upgrade on another paperboard manufacturing plant in Michigan. Once GPK completes construction in Texas, the company will have a low-cost position in the industry which will provide higher returns on invested capital and increased cash flow. We continue to believe that Graphic is well positioned to provide value to our fundholders as, with the return of volume growth and the completion of its capital projects, the company will show increasing ROIC and return increasing amounts of free cash flow to shareholders." Workers in protective gear carrying packages of coated unbleached kraft for shipping. Graphic Packaging Holding Company (NYSE:GPK) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 31 hedge fund portfolios held Graphic Packaging Holding Company (NYSE:GPK) at the end of the fourth quarter compared to 29 in the third quarter. While we acknowledge the potential of Graphic Packaging Holding Company (NYSE:GPK) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as NVIDIA but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock. We covered Graphic Packaging Holding Company (NYSE:GPK) in a previous article, where we shared the list of best boring stocks to buy. In addition, please check out our hedge fund investor letters Q4 2024 page for more investor letters from hedge funds and other leading investors. READ NEXT: Michael Burry Is Selling These Stocks and A New Dawn Is Coming to US Stocks. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
